Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

Should all patients at high cardiovascular risk receive renin-angiotensin system blockers?

Volpe M.

QJM. 2012 Jan;105(1):11-27. doi: 10.1093/qjmed/hcr190. Review.

PMID:
22011630
2.

RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.

Werner C, Baumhäkel M, Teo KK, Schmieder R, Mann J, Unger T, Yusuf S, Böhm M.

Clin Res Cardiol. 2008 Jul;97(7):418-31. doi: 10.1007/s00392-008-0668-3. Review.

PMID:
18454336
3.
4.
5.

Angiotensin II type 1 receptor blockade: high hopes sent back to reality?

Grothusen A, Divchev D, Luchtefeld M, Schieffer B.

Minerva Cardioangiol. 2009 Dec;57(6):773-85. Review.

PMID:
19942847
7.

ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.

Schindler C.

Ther Adv Cardiovasc Dis. 2008 Aug;2(4):233-48. doi: 10.1177/1753944708094309.

PMID:
19124424
8.

Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?

Werner C, Pöss J, Böhm M.

Drugs. 2010 Jul 9;70(10):1215-30. doi: 10.2165/11537910-000000000-00000. Review.

PMID:
20568830
9.

Blocking the renin-angiotensin system: dual- versus mono-therapy.

Ravandi A, Teo KK.

Expert Rev Cardiovasc Ther. 2009 Jun;7(6):667-74. doi: 10.1586/erc.09.47. Review.

PMID:
19505282
10.

The ongoing telmisartan alone and in combination with ramipril global endpoint trial program.

Unger T.

Am J Cardiol. 2003 May 22;91(10A):28G-34G. Review.

PMID:
12781906
12.

Recent changes in the landscape of combination RAS blockade.

Epstein BJ, Smith SM, Choksi R.

Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1373-84. doi: 10.1586/erc.09.127. Review.

PMID:
19900020
13.
14.

The cardiovascular continuum and renin-angiotensin-aldosterone system blockade.

Dzau V.

J Hypertens Suppl. 2005 Apr;23(1):S9-17. Review.

PMID:
15821452
15.
16.
18.
19.

The therapeutic role of RAS blockade in chronic heart failure.

Werner CM, Böhm M.

Ther Adv Cardiovasc Dis. 2008 Jun;2(3):167-77. doi: 10.1177/1753944708091777. Review.

PMID:
19124420
20.

Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum.

Chrysant SG.

Clin Ther. 2008;30 Pt 2:2181-90. doi: 10.1016/j.clinthera.2008.12.002. Review.

PMID:
19281913

Supplemental Content

Support Center